Cargando…

Diagnosis and treatment based on quantitative PCR after controlled human malaria infection

BACKGROUND: Controlled human malaria infection (CHMI) has become well-established in the evaluation of drugs and vaccines. Anti-malarial treatment is usually initiated when thick blood smears are positive by microscopy. This study explores the effects of using the more sensitive qPCR as the primary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walk, Jona, Schats, Remko, Langenberg, Marijke C. C., Reuling, Isaie J., Teelen, Karina, Roestenberg, Meta, Hermsen, Cornelus C., Visser, Leo G., Sauerwein, Robert W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974752/ https://www.ncbi.nlm.nih.gov/pubmed/27495296 http://dx.doi.org/10.1186/s12936-016-1434-z

Ejemplares similares

Erratum to: Diagnosis and treatment based on quantitative PCR after controlled human malaria infection
por: Walk, Jona, et al.
Publicado: (2016)

Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis
por: Felgner, Philip L., et al.
Publicado: (2013)

CORRIGENDUM: Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis
por: Felgner, Philip L., et al.
Publicado: (2014)

Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites
por: Schats, Remko, et al.
Publicado: (2015)

Cytotoxic Markers Associate With Protection Against Malaria in Human Volunteers Immunized With Plasmodium falciparum Sporozoites
por: Bijker, Else M., et al.
Publicado: (2014)

Memory B-Cell and Antibody Responses Induced by Plasmodium falciparum Sporozoite Immunization
por: Nahrendorf, Wiebke, et al.
Publicado: (2014)

Sporozoite Immunization of Human Volunteers under Mefloquine Prophylaxis Is Safe, Immunogenic and Protective: A Double-Blind Randomized Controlled Clinical Trial
por: Bijker, Else M., et al.
Publicado: (2014)

Semi-high-throughput detection of Plasmodium falciparum and Plasmodium vivax oocysts in mosquitoes using bead-beating followed by circumsporozoite ELISA and quantitative PCR
por: Graumans, Wouter, et al.
Publicado: (2017)

Controlled Human Malaria Infections by Intradermal Injection of Cryopreserved Plasmodium falciparum Sporozoites
por: Roestenberg, Meta, et al.
Publicado: (2013)

Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers
por: van Wolfswinkel, Marlies E., et al.
Publicado: (2017)

Antibody Biomarkers Associated with Sterile Protection Induced by Controlled Human Malaria Infection under Chloroquine Prophylaxis
por: Obiero, Joshua M., et al.
Publicado: (2019)

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection
por: Coffeng, Luc E., et al.
Publicado: (2017)

Longevity and Composition of Cellular Immune Responses Following Experimental Plasmodium falciparum Malaria Infection in Humans
por: Teirlinck, Anne C., et al.
Publicado: (2011)

Comparison of Clinical and Parasitological Data from Controlled Human Malaria Infection Trials
por: Roestenberg, Meta, et al.
Publicado: (2012)

NF135.C10: A New Plasmodium falciparum Clone for Controlled Human Malaria Infections
por: Teirlinck, Anne C., et al.
Publicado: (2013)

Activatory Receptor NKp30 Predicts NK Cell Activation During Controlled Human Malaria Infection
por: Walk, Jona, et al.
Publicado: (2019)

Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial
por: Walk, Jona, et al.
Publicado: (2017)

Biomarkers of cellular aging during a controlled human malaria infection
por: Miglar, Aurelie, et al.
Publicado: (2021)

In response to the letter to the editor by Dondorp et al. RE: Reuling et al., 2018 ‘liver injury in uncomplicated malaria is an overlooked phenomenon: An observational study’
por: Reuling, Isaie J., et al.
Publicado: (2021)

Outcomes of controlled human malaria infection after BCG vaccination
por: Walk, Jona, et al.
Publicado: (2019)

A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparum gametocytemia in the controlled human malaria infection model
por: Reuling, Isaie J, et al.
Publicado: (2018)

Liver Injury in Uncomplicated Malaria is an Overlooked Phenomenon: An Observational Study
por: Reuling, Isaie J., et al.
Publicado: (2018)

Controlled Human Malaria Infection with Graded Numbers of Plasmodium falciparum NF135.C10- or NF166.C8-Infected Mosquitoes
por: Langenberg, Marijke C. C., et al.
Publicado: (2018)

Filter paper collection of Plasmodium falciparum mRNA for detecting low-density gametocytes
por: Jones, Sophie, et al.
Publicado: (2012)

Evaluation of immunity against malaria using luciferase-expressing Plasmodium berghei parasites
por: Ploemen, Ivo, et al.
Publicado: (2011)

Antibodies against PfEMP1, RIFIN, MSP3 and GLURP Are Acquired during Controlled Plasmodium falciparum Malaria Infections in Naïve Volunteers
por: Turner, Louise, et al.
Publicado: (2011)

Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
por: Roestenberg, Meta, et al.
Publicado: (2008)

External Quality Assurance of Malaria Nucleic Acid Testing for Clinical Trials and Eradication Surveillance
por: Murphy, Sean C., et al.
Publicado: (2014)

A Plasmodium berghei sporozoite-based vaccination platform against human malaria
por: Mendes, António M., et al.
Publicado: (2018)

Antibody Responses to Antigenic Targets of Recent Exposure Are Associated With Low-Density Parasitemia in Controlled Human Plasmodium falciparum Infections
por: van den Hoogen, Lotus L., et al.
Publicado: (2019)

Improving statistical inference on pathogen densities estimated by quantitative molecular methods: malaria gametocytaemia as a case study
por: Walker, Martin, et al.
Publicado: (2015)

Cardiac complication after experimental human malaria infection: a case report
por: Nieman, An-Emmie, et al.
Publicado: (2009)

Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice
por: Nganou-Makamdop, Krystelle, et al.
Publicado: (2012)

A controlled human malaria infection model enabling evaluation of transmission-blocking interventions
por: Collins, Katharine A., et al.
Publicado: (2018)

Whole-blood transcriptomic signatures induced during immunization by chloroquine prophylaxis and Plasmodium falciparum sporozoites
por: Tran, Tuan M., et al.
Publicado: (2019)

Corrigendum: Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development
por: Roestenberg, Meta, et al.
Publicado: (2019)

Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development
por: Roestenberg, Meta, et al.
Publicado: (2018)

Long Term Protection after Immunization with P. berghei Sporozoites Correlates with Sustained IFNγ Responses of Hepatic CD8+ Memory T Cells
por: Nganou-Makamdop, Krystelle, et al.
Publicado: (2012)

A tracer-based method enables tracking of Plasmodium falciparum malaria parasites during human skin infection
por: Winkel, Béatrice M.F., et al.
Publicado: (2019)

Visualisation and Quantitative Analysis of the Rodent Malaria Liver Stage by Real Time Imaging
por: Ploemen, Ivo H. J., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_miqsu4g3rq3fmqf4ps834i1p8e